Ovarian cancer

• A clinical study of the safety and effectiveness of an investigational cell therapy given with and without an investigational RNA-based vacc … Recruiting
  2024-514962-38-00 1 2020-08-25 "Solid Tumors"
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or … Recruiting
  2023-507149-27-00 5 2019-11-04 "Chemotherapy-induced Thrombocytopenia in Adult subjects with"
• Phase 2 Pan-Tumor Trial of R-DXd for Advanced/Metastatic Solid Tumors Recruitment ended
  2024-513307-13-00 4 2025-05-26 "Advanced/metastatic solid tumors including gynecological can"
• A phase I, open-label, multi-center study of KFA115 as a single agent and in combination with pembrolizumab in patients with select advanced … Recruitment ended
  2022-502381-25-01 1 2024-03-15 "Thymic Carcinoma"
• Phase I, double-blind, randomized, placebo-controlled study investigating the safety, tolerability and concentrations of the study product K … Recruitment ended
  2023-503909-11-01 1 2023-10-30
• A clinical trial of relacorilant (study drug) with nab-paclitaxel in patients with ovarian, fallopian tube or peritoneal cancer Recruitment ended
  2024-514080-25-00 5 2023-04-21 "Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian,"
• PHASE 1/2A DOSE ESCALATION, FINDING AND EXPANSION STUDY EVALUATING SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTI TUMOR A … Recruitment ended
  2024-515492-34-00 9 2023-03-30 "Breast Cancer, Ovarian Cancer, SCLC (Part 1 also had TNBC an"
• An Open-Label Phase 1/2 Trial to Evaluate the Safety, Tolerability, and Efficacy of MORAb 202 in Subjects with Selected Tumor Types. Recruitment ended
  2023-506868-14-00 9 2023-02-28 "Solid tumors in 4 tumor types: platinum resistant ovarian ca"
• Evaluation of two maintenance therapies (OSE2101 alone or in combination with pembrolizumab) versus best supportive care in patient with pla … Recruitment ended
  2024-516096-32-00 4 2021-08-05 "Platinum sensitive recurrent ovarian cancer"
• Comparing Paclitaxel-Carboplatin-Oregovomab versus Paclitaxel-Carboplatin-Placebo in Patients with Advanced Ovarian Cancer Recruitment ended
  2024-519218-30-00 5 2021-05-26 "Advanced epithelial ovarian, fallopian tube or peritoneal ca"
• ADP-A2M4CD8 in advanced cancers Recruitment ended
  2024-512864-71-00 3 2020-05-27 "Urothelial cancer Esophageal cancer Gastric cancer Non-smal"
• A randomized double blind, multicenter trial to assess time-interval between cytoreductive surgery and adjuvant chemotherapy after administr … Recruitment ended
  2023-507732-20-00 5 2019-11-29 "Advanced epithelial ovarian cancer stage III-IV"
• An open label, multicenter extension study in patients previously enrolled in a Genentch and/or F. Hoffmann-La Roche Ltd sponsored atezolizu … Recruitment ended
  2023-506184-34-00 5 2019-08-09 "Advanced Malignancies"
• A Phase 1b Dose Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Adv … Recruitment ended
  2024-516477-73-00 3 2018-03-07 "Bladder cancer and kidney cancer"
• A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants Ended
  2024-518696-65-00 3 2025-08-12 "(HR) -positive human epidermal growth factor receptor 2 (HER"
• A trial to learn how safe saruparib is and how well it works in people with advanced ovarian cancer Ended
  2024-519044-32-00 9 2025-08-06 "Advanced/Recurrent Ovarian cancer"
• A Study of ZW171 in Participants with Advanced or Metastatic Mesothelin Expressing Cancers Ended
  2024-511119-11-00 1 2025-03-07 "Advanced or metastatic ovarian cancer, NSCLC, pancreatic can"
• A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-A3 … Ended
  2023-505322-34-00 1 2024-01-08 "Advanced or metastatic solid tumors"
• Part C of A Phase 1b/2a Study of LY2880070 in Patients with Advanced or Metastatic Cancer Ended
  2023-503459-91-00 4 2023-11-21 "Advanced or Metastatic Cancer"
• 68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging of Patients with Ovarian Cancer Ended
  2023-505938-98-00 4 2023-11-17 "Ovarian Cancer"
• Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors Ended
  2022-502867-39-00 1 2023-09-29 "Advanced solid tumors including non-small cell lung cancer ("
• KANDOVA An open multicenter study to evaluate the safety and tolerability of KAND567, in combination with carboplatin therapy, and to determ … Ended
  2024-515572-13-00 9 2023-04-26 "Recurrent epithelial ovarian, fallopian tube, or primary per"
• A Phase 2 Study of MORAb-202 in Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Ended
  2023-504111-33-00 4 2023-02-14 "Platinum-resistant High-grade Serous Ovarian, Primary Perito"
• Study of Nemvaleukin Alfa in Combination with Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients with Platinum-Resistant Ep … Ended
  2024-513230-38-00 5 2022-12-15 "Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Pr"

Showing 49–72 of 82 trials